Einar Ponten
Lipum's CEO looks forward to 2024
In 2023, Lipum has primarily focused on its clinical phase I study with SOL-116. With the help of a capital raise in...
Intervju
Lipum's SOL-116 attracted interest at BIO-Europe
November 6-8 was once again the time for...
Intervju
Ola Sandborgh takes over as CEO of Lipum
Lipum has appointed Ola Sandborgh as new CEO...
Intervju
Lipum reports Q2 and increases the pace
In its second quarter report, the biopharmaceutical company announces...
Lipum accelerates clinical development
Lipum
BioStock Coffee Break: Einar Pontén, CEO of Lipum
Lipum's CEO Einar Pontén is a guest on BioStock's podcast Coffee...
Intervju
Video
Lipum aims to complete Phase I study faster
Intervju
Lipum on financial statements and BIO-Europe
The biopharmaceutical company Lipum recently published its financial statement for 2022...
Intervju
Lipum's clinical development journey continues in 2023
2022 was the year when the biopharmaceutical company Lipum...
Intervju
Lipum exits Q3 as a clinical development company
In Lipum's quarterly report, CEO Einar Pontén says that...
Intervju
Lipum's CEO on the potential for life science in Umeå
The life science industry is growing stronger in Umeå...
Intervju
Torgny Stigbrand about the investment in Lipum
In October, Lipum carried out a directed new share issue of...
Intervju